Work

Epidermal growth factor receptor (EGFR) inhibitor PD153035 reverses ABCG2-mediated multidrug resistance in non-small cell lung cancer: In vitro and in vivo

Year: 2018

Type: article

Source: Cancer Letters

DOI: 10.1016/j.canlet.2018.02.040

Authors: Guan-Nan Zhang, Yun-Kai Zhang, Yi-Jun Wang, Pranav Gupta, Charles R. Ashby, Saeed Alqahtani, Tongjin Deng, Susan E. Bates, Amal Kaddoumi, John N.D. Wurpel, Yi-Xiong Lei, Zhe-Sheng Chen

Institutions: St. John's University, University of Louisiana at Monroe, Columbia University Irving Medical Center, Guangzhou Medical University

Language: English

Topic: Drug Transport and Resistance Mechanisms

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Pfizer, RayBiotech, Department of Pharmaceutical Sciences, St. John's University

OpenAlex ID: W2790939547

FWCI: 2.779

Cites: 51

Cited by: 60

Related to: 10